[Nephrotoxicity of gentamycin used in hepatic and biliary diseases].
Authors discuss nephrotoxicity of aminoglycosides in patients with hepatic and biliary disorders. It may be concluded that hepatic and biliary diseases should be considered as an additional gentamycin nephrotoxicity risk factor. Administration of gentamycin to such patients require dose adjustments to renal function and--if possible--to gentamycin serum level.
Debska-Slizień
A
A
Kliniki Chorób Nerek Instytutu Chorób Wewnetrznych AM, Gdańsku.
Rutkowski
B
B
D001660:Biliary Tract Diseases / Q000188:drug therapy*; D005260:Female; D005839:Gentamicins / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D008107:Liver Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D005839:Gentamicins
Nefrotoksyczność gentamycyny podawanej w chorobach watroby i dróg zółciowych.